Delivery Order SPE2DB25D3020-SPE2DB25FWGAD

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,147.21, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of bupropion hydrochloride extended-release tablets, a pharmaceutical product used to treat depression. This delivery order contract has a firm fixed price pricing type and is scheduled for completion by April 10, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,069.41 firm fixed-price delivery order is for the supply of 500 units of Bupropion HCL XL 150 mg tablets, a medication used for the treatment of depression and other mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award, valued at $30,984.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The contract covers the delivery of Bupropion HCL XL 150 mg tablets, a...
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets, which are prescribed for the treatment of depression and other mental health conditions. The contract, valued at $3,837.38, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.13 firm fixed-price delivery order is for the supply of Bupropion HCL XL 300 mg tablets, a medication used to treat depression and other conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $28,839.88 order is for the provision of 150mg Bupropion hydrochloride extended-release tablets, a generic antidepressant medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a generic pharmaceutical product used to treat depression and other conditions. The contract has a ceiling value of $60,554.02 and is structured as a Firm Fixed Price delivery order, with a period of performance ending on April 30, 2024. This contract award...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,176.35, is for the delivery of bupropion hydrochloride extended-release tablets in quantities of 500 per bottle. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the period of performance runs through January 17, 2024. This award is part of a larger Indefinite...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 150 mg Bupropion HCL XL tablets, a generic medication used for the treatment of depression. The award has a ceiling value of $1,160.61 and a completion date of December 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,015.60 fixed-price delivery order contract is for the supply of Bupropion HCL XL 150 mg tablets, a generic medication used to treat depression and other conditions. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWGAD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,890.10, is for the delivery of bupropion hydrochloride extended-release tablets, a medication used to treat depression and other mental health conditions.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:17 AM